Unity and diversity in the human adenoviruses: Exploiting alternative entry pathways for gene therapy

Biochemical Journal

Volumn 431, Issue 3, 2010, Pages 321-336

  Hall, Kathryn ^a   Blair Zajdel, Maria E ^b   Blair, G Eric ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

Adenovirus; Fibre protein; Gene therapy; Oncolytic virus; Viral receptor

Indexed keywords

CELL MEMBRANES; FIBERS; GENE TRANSFER; PROTEINS; VIRUSES;

ADENOVIRUS; CANCER THERAPY; CELL SURFACES; CELL TYPES; CELLULAR ATTACHMENTS; DOUBLE STRANDED DNA; ENVELOPED VIRUS; FIBRE PROTEIN; HUMAN ADENOVIRUS; HUMAN CELLS; ICOSAHEDRAL SYMMETRY; INTEGRINS; ONCOLYTIC VIRUS; REGULATORY PROTEIN; SEROTYPES; TWO-STEP PROCESS; VIRAL RECEPTOR;

GENE THERAPY;

DOUBLE STRANDED DNA; REGULATOR PROTEIN; VIRUS FIBER PROTEIN; PROTEIN BINDING; VIRUS PROTEIN;

CANCER GENE THERAPY; CELL SURFACE; GENE THERAPY; GENE TRANSFER; GENOME; HUMAN ADENOVIRUS; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SEROTYPE; TUMOR GROWTH; VIROGENESIS; VIRUS ATTACHMENT; VIRUS CAPSID; VIRUS ENTRY; VIRUS MORPHOLOGY; VIRUS REPLICATION; ANIMAL; CHEMISTRY; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

ADENOVIRIDAE; HUMAN ADENOVIRUS; MIRIDAE;

ADENOVIRUSES, HUMAN; ANIMALS; GENETIC THERAPY; HUMANS; PROTEIN BINDING; VIRAL PROTEINS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 78049287281     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20100766     Document Type: Review

References (207)

1. Howley, P. M. and Livingston, D. M. (2009) Small DNA tumor viruses: large contributors to biomedical sciences. Virology 384, 256-259
2. Berk, A. J. (2005) Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 24, 7673-7685
3. Wold, W. S. M. and Horwitz, M. S. (2007) Adenoviruses. In Fields Virology: Volume Two (Knipe, D. M. and Howley, P. M., eds), pp. 2395-2436, Lippincott Williams & Wilkins, Philadelphia
4. Yamamoto, M. and Curiel, D.T. (2010) Current issues and future directions of oncolytic adenoviruses. Mol. Ther. 18, 243-250
5. Russell, W. C. (2009) Adenoviruses: update on structure and function. J. Gen. Virol. 90, 1-20
6. Havenga, M. J., Lemckert, A. A., Ophorst, O. J., van Meijer, M., Germeraad, W. T., Grimbergen, J., van Den Doel, M. A., Vogels, R., van Deutekom, J., Janson, A. A. et al. (2002) Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease. J. Virol. 76, 4612-4620
7. Tibbetts, C. (1977) Physical organization of subgroup B human adenovirus genomes. J. Virol. 24, 564-579
8. Vellinga, J., Van der Heijdt, S. and Hoeben, R. C. (2005) The adenovirus capsid: major progress in minor proteins. J. Gen. Virol. 86, 1581-1588
9. Nemerow, G. R., Pache, L., Reddy, V. and Stewart, P. L. (2009) Insights into adenovirus host cell interactions from structural studies. Virology 384, 380-388
10. Kidd, A. H., Chroboczek, J., Cusack, S. and Ruigrok, R. W. (1993) Adenovirus type 40 virions contain two distinct fibers. Virology 192, 73-84
11. Seiradake, E. and Cusack, S. (2005) Crystal structure of enteric adenovirus serotype 41 short fiber head. J. Virol. 79, 14088-14094
12. Jones, II, M. S., Harrach, B., Ganac, R. D., Gozum, M. M., Dela Cruz, W. P., Riedel, B., Pan, C., Delwart, E. L. and Schnurr, D. P. (2007) New adenovirus species found in a patient presenting with gastroenteritis. J. Virol. 81, 5978-5984
13. Zubieta, C., Schoehn, G., Chroboczek, J. and Cusack, S. (2005) The structure of the human adenovirus 2 penton. Mol. Cell 17, 121-135
14. Tarassishin, L., Szawlowski, P., Kidd, A. H. and Russell, W. C. (2000) An epitope on the adenovirus fibre tail is common to all human subgroups. Arch. Virol. 145, 805-811
15. Hong, J. S. and Engler, J. A. (1996) Domains required for assembly of adenovirus type 2 fiber trimers. J. Virol. 70, 7071-7078
16. Green, N. M., Wrigley, N. G., Russell, W. C., Martin, S. R. and McLachlan, A. D. (1983) Evidence for a repeating cross-β sheet structure in the adenovirus fibre. EMBO J. 2, 1357-1365
17. Ruigrok, R. W., Barge, A., Albiges-Rizo, C. and Dayan, S. (1990) Structure of adenovirus fibre. II. Morphology of single fibres. J. Mol. Biol. 215, 589-596
18. van Raaij, M. J., Mitraki, A., Lavigne, G. and Cusack, S. (1999) A triple β-spiral in the adenovirus fibre shaft reveals a new structural motif for a fibrous protein. Nature 401, 935-938
19. Chroboczek, J., Ruigrok, R. W. and Cusack, S. (1995) Adenovirus fiber. Curr. Top. Microbiol. Immunol. 199, 163-200
20. Wu, E., Pache, L., Von Seggern, D. J., Mullen, T. M., Mikyas, Y., Stewart, P. L. and Nemerow, G. R. (2003) Flexibility of the adenovirus fiber is required for efficient receptor interaction. J. Virol. 77, 7225-7235
21. Persson, B. D., Reiter, D. M., Marttila, M., Mei, Y. F., Casasnovas, J. M., Arnberg, N. and Stehle, T. (2007) Adenovirus type 11 binding alters the conformation of its receptor CD46. Nat. Struct. Mol. Biol. 14, 164-166
22. van Raaij, M. J., Louis, N., Chroboczek, J. and Cusack, S. (1999) Structure of the human adenovirus serotype 2 fiber head domain at 1.5 Å resolution. Virology 262, 333-343
23. Xia, D., Henry, L. J., Gerard, R. D. and Deisenhofer, J. (1994) Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 Å resolution. Structure 2, 1259-1270
24. Durmort, C., Stehlin, C., Schoehn, G., Mitraki, A., Drouet, E., Cusack, S. and Burmeister, W. P. (2001) Structure of the fiber head of Ad3, a non-CAR-binding serotype of adenovirus. Virology 285, 302-312
25. Persson, B. D., Muller, S., Reiter, D. M., Schmitt, B. B., Marttila, M., Sumowski, C. V., Schweizer, S., Scheu, U., Ochsenfeld, C., Arnberg, N. and Stehle, T. (2009) An arginine switch in the species B adenovirus knob determines high-affinity engagement of cellular receptor CD46. J. Virol. 83, 673-686
26. Pache, L., Venkataraman, S., Nemerow, G. R. and Reddy, V. S. (2008) Conservation of fiber structure and CD46 usage by subgroup B2 adenoviruses. Virology 375, 573-579
27. Pache, L., Venkataraman, S., Reddy, V. S. and Nemerow, G. R. (2008) Structural variations in species B adenovirus fibers impact CD46 association. J. Virol. 82, 7923-7931
28. Cupelli, K., Muller, S., Persson, B. D., Jost, M., Arnberg, N. and Stehle, T. (2010) Structure of adenovirus type 21 knob in complex with CD46 reveals key differences in receptor contacts among species B adenoviruses. J. Virol. 84, 3189-3200
29. Meier, O. and Greber, U. F. (2004) Adenovirus endocytosis. J. Gene Med. 6 (Suppl. 1), S152-S163
30. Leopold, P. L. and Crystal, R. G. (2007) Intracellular trafficking of adenovirus: many means to many ends. Adv. Drug Delivery Rev. 59, 810-821
31. Lonberg-Holm, K., Crowell, R. L. and Philipson, L. (1976) Unrelated animal viruses share receptors. Nature 259, 679-681
32. Zhang, Y. and Bergelson, J. M. (2005) Adenovirus receptors. J. Virol. 79, 12125-12131
33. Philipson, L. and Pettersson, R. F. (2004) The coxsackie-adenovirus receptor: a new receptor in the immunoglobulin family involved in cell adhesion. Curr. Top. Microbiol. Immunol. 273, 87-111
34. Tomko, R. P., Xu, R. and Philipson, L. (1997) HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. U.S.A. 94, 3352-3356
35. Thoelen, I., Keyaerts, E., Lindberg, M. and Van Ranst, M. (2001) Characterization of a cDNA encoding the bovine coxsackie and adenovirus receptor. Biochem. Biophys. Res. Commun. 288, 805-808
36. Roelvink, P. W., Lizonova, A., Lee, J. G., Li, Y., Bergelson, J. M., Finberg, R. W., Brough, D. E., Kovesdi, I. and Wickham, T. J. (1998) The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J. Virol. 72, 7909-7915
37. Bewley, M. C., Springer, K., Zhang, Y. B., Freimuth, P. and Flanagan, J. M. (1999) Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science 286, 1579-1583
38. Roelvink, P. W., Mi Lee, G., Einfeld, D. A., Kovesdi, I. and Wickham, T. J. (1999) Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. Science 286, 1568-1571
39. Walters, R. W., Freimuth, P., Moninger, T. O., Ganske, I., Zabner, J. and Welsh, M. J. (2002) Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape. Cell 110, 789-799
40. Excoffon, K.J., Gansemer, N.D., Mobily, M.E., Karp, P.H., Parekh, K.R. and Zabner, J. (2010) Isoform-specific regulation and localization of the coxsackie and adenovirus receptor in human airway epithelia. PLoS ONE 5, e9909
41. Dechecchi, M. C., Melotti, P., Bonizzato, A., Santacatterina, M., Chilosi, M. and Cabrini, G. (2001) Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J. Virol. 75, 8772-8780
42. Chu, Y., Heistad, D., Cybulsky, M. I. and Davidson, B. L. (2001) Vascular cell adhesion molecule-1 augments adenovirus-mediated gene transfer. Arterioscler. Thromb. Vasc. Biol. 21, 238-242
43. Fechner, H., Haack, A., Wang, H., Wang, X., Eizema, K., Pauschinger, M., Schoemaker, R., Veghel, R., Houtsmuller, A., Schultheiss, H. P., Lamers, J. and Poller, W. (1999) Expression of coxsackie adenovirus receptor and ?v-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Ther. 6, 1520-1535
44. Lieber, A., He, C. Y., Meuse, L., Schowalter, D., Kirillova, I., Winther, B. and Kay, M. A. (1997) The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J. Virol. 71, 8798-8807
45. Shayakhmetov, D. M., Li, Z. Y., Ni, S. and Lieber, A. (2004) Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors. J. Virol. 78, 5368-5381
46. Young, L. S. and Mautner, V. (2001) The promise and potential hazards of adenovirus gene therapy. Gut 48, 733-736
47. Alemany, R. and Curiel, D. T. (2001) CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther. 8, 1347-1353
48. Martin, K., Brie, A., Saulnier, P., Perricaudet, M., Yeh, P. and Vigne, E. (2003) Simultaneous CAR- and αV integrin-binding ablation fails to reduce Ad5 liver tropism. Mol. Ther. 8, 485-494
49. Shayakhmetov, D. M., Gaggar, A., Ni, S., Li, Z. Y. and Lieber, A. (2005) Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J. Virol. 79, 7478-7491
50. Parker, A. L., Waddington, S. N., Nicol, C. G., Shayakhmetov, D. M., Buckley, S. M., Denby, L., Kemball-Cook, G., Ni, S., Lieber, A., McVey, J. H. et al. (2006) Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood 108, 2554-2561
51. Parker, A. L., McVey, J. H., Doctor, J. H., Lopez-Franco, O., Waddington, S. N., Havenga, M. J., Nicklin, S. A. and Baker, A. H. (2007) Influence of coagulation factor zymogens on the infectivity of adenoviruses pseudotyped with fibers from subgroup D. J. Virol. 81, 3627-3631
52. Ni, S., Bernt, K., Gaggar, A., Li, Z. Y., Kiem, H. P. and Lieber, A. (2005) Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons. Hum. Gene Ther. 16, 664-677
53. Schoggins, J. W., Gall, J. G. and Falck-Pedersen, E. (2003) Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitroand in vivo. J. Virol. 77, 1039-1048
54. Waddington, S. N., McVey, J. H., Bhella, D., Parker, A. L., Barker, K., Atoda, H., Pink, R., Buckley, S. M., Greig, J. A., Denby, L. et al. (2008) Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132, 397-409
55. Kalyuzhniy, O., Di Paolo, N. C., Silvestry, M., Hofherr, S. E., Barry, M. A., Stewart, P. L. and Shayakhmetov, D. M. (2008) Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc. Natl. Acad. Sci. U.S.A. 105, 5483-5488
56. Alba, R., Bradshaw, A. C., Parker, A. L., Bhella, D., Waddington, S. N., Nicklin, S. A., van Rooijen, N., Custers, J., Goudsmit, J., Barouch, D. H. et al. (2009) Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood 114, 965-971
57. Tallone, T., Malin, S., Samuelsson, A., Wilbertz, J., Miyahara, M., Okamoto, K., Poellinger, L., Philipson, L. and Pettersson, S. (2001) A mouse model for adenovirus gene delivery. Proc. Natl. Acad. Sci. U.S.A. 98, 7910-7915
58. Wadell, G., Hammarskjold, M. L., Winberg, G., Varsanyi, T. M. and Sundell, G. (1980) Genetic variability of adenoviruses. Ann. N.Y. Acad. Sci. 354, 16-42
59. Wadell, G. (1984) Molecular epidemiology of human adenoviruses. Curr. Top. Microbiol. Immunol. 110, 191-220
60. Segerman, A., Arnberg, N., Erikson, A., Lindman, K. and Wadell, G. (2003) There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses. J. Virol. 77, 1157-1162
61. Gaggar, A., Shayakhmetov, D. M. and Lieber, A. (2003) CD46 is a cellular receptor for group B adenoviruses. Nat. Med. 9, 1408-1412
62. Sirena, D., Lilienfeld, B., Eisenhut, M., Kalin, S., Boucke, K., Beerli, R. R., Vogt, L., Ruedl, C., Bachmann, M. F., Greber, U. F. and Hemmi, S. (2004) The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3. J. Virol. 78, 4454-4462
63. Segerman, A., Atkinson, J. P., Marttila, M., Dennerquist, V., Wadell, G. and Arnberg, N. (2003) Adenovirus type 11 uses CD46 as a cellular receptor. J. Virol. 77, 9183-9191
64. Marttila, M., Persson, D., Gustafsson, D., Liszewski, M. K., Atkinson, J. P., Wadell, G. and Arnberg, N. (2005) CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7. J. Virol. 79, 14429-14436
65. Cattaneo, R. (2004) Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J. Virol. 78, 4385-4388
66. Liszewski, M. K., Kemper, C., Price, J. D. and Atkinson, J. P. (2005) Emerging roles and new functions of CD46. Springer Semin. Immunopathol. 27, 345-358
67. Riley-Vargas, R. C., Gill, D. B., Kemper, C., Liszewski, M. K. and Atkinson, J. P. (2004) CD46: expanding beyond complement regulation. Trends Immunol. 25, 496-503
68. Crimeen-Irwin, B., Ellis, S., Christiansen, D., Ludford-Menting, M. J., Milland, J., Lanteri, M., Loveland, B. E., Gerlier, D. and Russell, S. M. (2003) Ligand binding determines whether CD46 is internalized by clathrin-coated pits or macropinocytosis. J. Biol. Chem. 278, 46927-46937
69. Sakurai, F., Murakami, S., Kawabata, K., Okada, N., Yamamoto, A., Seya, T., Hayakawa, T. and Mizuguchi, H. (2006) The short consensus repeats 1 and 2, not the cytoplasmic domain, of human CD46 are crucial for infection of subgroup B adenovirus serotype 35. J. Controlled Release 113, 271-278
70. Fleischli, C., Verhaagh, S., Havenga, M., Sirena, D., Schaffner, W., Cattaneo, R., Greber, U. F. and Hemmi, S. (2005) The distal short consensus repeats 1 and 2 of the membrane cofactor protein CD46 and their distance from the cell membrane determine productive entry of species B adenovirus serotype 35. J. Virol. 79, 10013-10022
71. Gaggar, A., Shayakhmetov, D. M., Liszewski, M. K., Atkinson, J. P. and Lieber, A. (2005) Localization of regions in CD46 that interact with adenovirus. J. Virol. 79, 7503-7513
72. Fleischli, C., Sirena, D., Lesage, G., Havenga, M. J., Cattaneo, R., Greber, U. F. and Hemmi, S. (2007) Species B adenovirus serotypes 3, 7, 11 and 35 share similar binding sites on the membrane cofactor protein CD46 receptor. J. Gen. Virol. 88, 2925-2934
73. Hall, K., Blair Zajdel, M. E. and Blair, G. E. (2009) Defining the role of CD46, CD80 and CD86 in mediating adenovirus type 3 fiber interactions with host cells. Virology 392, 222-229
74. Short, J. J., Pereboev, A. V., Kawakami, Y., Vasu, C., Holterman, M. J. and Curiel, D. T. (2004) Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors. Virology 322, 349-359
75. Short, J. J., Vasu, C., Holterman, M. J., Curiel, D. T. and Pereboev, A. (2006) Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors. Virus Res. 122, 144-153
76. Ulasov, I. V., Rivera, A. A., Han, Y., Curiel, D. T., Zhu, Z. B. and Lesniak, M. S. (2007) Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells. J. Neurosurg. 107, 617-627
77. Wickham, T. J., Mathias, P., Cheresh, D. A. and Nemerow, G. R. (1993) Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment. Cell 73, 309-319
78. Wickham, T. J., Filardo, E. J., Cheresh, D. A. and Nemerow, G. R. (1994) Integrin αvβ5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell Biol. 127, 257-264
79. Mathias, P., Wickham, T., Moore, M. and Nemerow, G. (1994) Multiple adenovirus serotypes use αv integrins for infection. J. Virol. 68, 6811-6814
80. Nemerow, G. R. and Stewart, P. L. (1999) Role of αv integrins in adenovirus cell entry and gene delivery. Microbiol. Mol. Biol. Rev. 63, 725-734
81. Hynes, R. O., Lively, J. C., McCarty, J. H., Taverna, D., Francis, S. E., Hodivala-Dilke, K. and Xiao, Q. (2002) The diverse roles of integrins and their ligands in angiogenesis. Cold Spring Harbor Symp. Quant. Biol. 67, 143-153
82. Bergelson, J. M., Shepley, M. P., Chan, B. M., Hemler, M. E. and Finberg, R. W. (1992) Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 255, 1718-1720
83. Jackson, T., Blakemore, W., Newman, J. W., Knowles, N. J., Mould, A. P., Humphries, M. J. and King, A. M. (2000) Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin α5β1: influence of the leucine residue within the RGDL motif on selectivity of integrin binding. J. Gen. Virol. 81, 1383-1391
84. Feire, A. L., Koss, H. and Compton, T. (2004) Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc. Natl. Acad. Sci. U.S.A. 101, 15470-15475
85. Van Nhieu, G. T. and Isberg, R. R. (1991) The Yersinia pseudotuberculosis invasin protein and human fibronectin bind to mutually exclusive sites on the α5β1 integrin receptor. J. Biol. Chem. 266, 24367-24375
86. Stewart, P. L. and Nemerow, G. R. (2007) Cell integrins: commonly used receptors for diverse viral pathogens. Trends Microbiol. 15, 500-507
87. Davison, A. J., Telford, E. A., Watson, M. S., McBride, K. and Mautner, V. (1993) The DNA sequence of adenovirus type 40. J. Mol. Biol. 234, 1308-1316
88. Li, E., Stupack, D., Bokoch, G. M. and Nemerow, G. R. (1998) Adenovirus endocytosis requires actin cytoskeleton reorganization mediated by Rho family GTPases. J. Virol. 72, 8806-8812
89. Li, E., Stupack, D., Klemke, R., Cheresh, D. A. and Nemerow, G. R. (1998) Adenovirus endocytosis via αv integrins requires phosphoinositide-3-OH kinase. J. Virol. 72, 2055-2061
90. Meier, O., Boucke, K., Hammer, S. V., Keller, S., Stidwill, R. P., Hemmi, S. and Greber, U. F. (2002) Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J. Cell Biol. 158, 1119-1131
91. Wang, K., Huang, S., Kapoor-Munshi, A. and Nemerow, G. (1998) Adenovirus internalization and infection require dynamin. J. Virol. 72, 3455-3458
92. Greber, U. F., Willetts, M., Webster, P. and Helenius, A. (1993) Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75, 477-486
93. Nakano, M. Y., Boucke, K., Suomalainen, M., Stidwill, R. P. and Greber, U. F. (2000) The first step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol. J. Virol. 74, 7085-7095
94. Martin-Fernandez, M., Longshaw, S. V., Kirby, I., Santis, G., Tobin, M. J., Clarke, D. T. and Jones, G. R. (2004) Adenovirus type-5 entry and disassembly followed in living cells by FRET, fluorescence anisotropy, and FLIM. Biophys. J. 87, 1316-1327
95. Amstutz, B., Gastaldelli, M., Kalin, S., Imelli, N., Boucke, K., Wandeler, E., Mercer, J., Hemmi, S. and Greber, U. F. (2008) Subversion of CtBP1-controlled macropinocytosis by human adenovirus serotype 3. EMBO J. 27, 956-969
96. Pernet, O., Pohl, C., Ainouze, M., Kweder, H. and Buckland, R. (2009) Nipah virus entry can occur by macropinocytosis. Virology 395, 298-311
97. Mercer, J. and Helenius, A. (2009) Virus entry by macropinocytosis. Nat. Cell Biol. 11, 510-520
98. Kalin, S., Amstutz, B., Gastaldelli, M., Wolfrum, N., Boucke, K., Havenga, M., DiGennaro, F., Liska, N., Hemmi, S. and Greber, U. F. (2010) Macropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35. J. Virol. 84, 5336-5350
99. Greber, U. F. (1998) Virus assembly and disassembly: the adenovirus cysteine protease as a trigger factor. Rev. Med. Virol. 8, 213-222
100. Wiethoff, C. M., Wodrich, H., Gerace, L. and Nemerow, G. R. (2005) Adenovirus protein VI mediates membrane disruption following capsid disassembly. J. Virol. 79, 1992-2000
101. Shayakhmetov, D. M., Li, Z. Y., Ternovoi, V., Gaggar, A., Gharwan, H. and Lieber, A. (2003) The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses. J. Virol. 77, 3712-3723
102. Miyazawa, N., Crystal, R. G. and Leopold, P. L. (2001) Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein. J. Virol. 75, 1387-1400
103. Miyazawa, N., Leopold, P. L., Hackett, N. R., Ferris, B., Worgall, S., Falck-Pedersen, E. and Crystal, R. G. (1999) Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors. J. Virol. 73, 6056-6065
104. Dales, S. and Chardonnet, Y. (1973) Early events in the interaction of adenoviruses with HeLa cells. IV. Association with microtubules and the nuclear pore complex during vectorial movement of the inoculum. Virology 56, 465-483
105. Mabit, H., Nakano, M. Y., Prank, U., Saam, B., Dohner, K., Sodeik, B. and Greber, U. F. (2002) Intact microtubules support adenovirus and herpes simplex virus infections. J. Virol. 76, 9962-9971
106. Kelkar, S., De, B. P., Gao, G., Wilson, J. M., Crystal, R. G. and Leopold, P. L. (2006) A common mechanism for cytoplasmic dynein-dependent microtubule binding shared among adeno-associated virus and adenovirus serotypes. J. Virol. 80, 7781-7785
107. Warren, J. C. and Cassimeris, L. (2007) The contributions of microtubule stability and dynamic instability to adenovirus nuclear localization efficiency. Cell Motil. Cytoskeleton 64, 675-689
108. Suomalainen, M., Nakano, M. Y., Keller, S., Boucke, K., Stidwill, R. P. and Greber, U. F. (1999) Microtubule-dependent plus- and minus end-directed motilities are competing processes for nuclear targeting of adenovirus. J. Cell Biol. 144, 657-672
109. Suomalainen, M., Nakano, M. Y., Boucke, K., Keller, S. and Greber, U. F. (2001) Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus. EMBO J. 20, 1310-1319
110. Leopold, P. L., Kreitzer, G., Miyazawa, N., Rempel, S., Pfister, K. K., Rodriguez-Boulan, E. and Crystal, R. G. (2000) Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Hum. Gene Ther. 11, 151-165
111. Wodrich, H., Henaff, D., Jammart, B., Segura-Morales, C., Seelmeir, S., Coux, O., Ruzsics, Z., Wiethoff, C. M. and Kremer, E. J. (2010) A capsid-encoded PPxY-motif facilitates adenovirus entry. PLoS Pathog. 6, e1000808
112. Strunze, S., Trotman, L. C., Boucke, K. and Greber, U. F. (2005) Nuclear targeting of adenovirus type 2 requires CRM1-mediated nuclear export. Mol. Biol. Cell 16, 2999-3009
113. Trotman, L. C., Mosberger, N., Fornerod, M., Stidwill, R. P. and Greber, U. F. (2001) Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat. Cell Biol. 3, 1092-1100
114. Greber, U. F., Suomalainen, M., Stidwill, R. P., Boucke, K., Ebersold, M. W. and Helenius, A. (1997) The role of the nuclear pore complex in adenovirus DNA entry. EMBO J. 16, 5998-6007
115. Saphire, A. C., Guan, T., Schirmer, E. C., Nemerow, G. R. and Gerace, L. (2000) Nuclear import of adenovirus DNA in vitro involves the nuclear protein import pathway and hsc70. J. Biol. Chem. 275, 4298-4304
116. Hindley, C. E., Lawrence, F. J. and Matthews, D. A. (2007) A role for transportin in the nuclear import of adenovirus core proteins and DNA. Traffic 8, 1313-1322
117. Haruki, H., Okuwaki, M., Miyagishi, M., Taira, K. and Nagata, K. (2006) Involvement of template-activating factor I/SET in transcription of adenovirus early genes as a positive-acting factor. J. Virol. 80, 794-801
118. Hong, S. S., Szolajska, E., Schoehn, G., Franqueville, L., Myhre, S., Lindholm, L., Ruigrok, R. W., Boulanger, P. and Chroboczek, J. (2005) The 100K-chaperone protein from adenovirus serotype 2 (Subgroup C) assists in trimerization and nuclear localization of hexons from subgroups C and B adenoviruses. J. Mol. Biol. 352, 125-138
119. Fender, P., Ruigrok, R. W., Gout, E., Buffet, S. and Chroboczek, J. (1997) Adenovirus dodecahedron, a new vector for human gene transfer. Nat. Biotechnol. 15, 52-56
120. Kauffman, R. S. and Ginsberg, H. S. (1976) Characterization of a temperature-sensitive, hexon transport mutant of type 5 adenovirus. J. Virol. 19, 643-658
121. Fessler, S. P. and Young, C. S. (1999) The role of the L4 33K gene in adenovirus infection. Virology 263, 507-516
122. Franqueville, L., Henning, P., Magnusson, M., Vigne, E., Schoehn, G., Blair-Zajdel, M. E., Habib, N., Lindholm, L., Blair, G. E., Hong, S. S. and Boulanger, P. (2008) Protein crystals in Adenovirus type 5-infected cells: requirements for intranuclear crystallogenesis, structural and functional analysis. PLoS ONE 3, e2894
123. Ostapchuk, P., Yang, J., Auffarth, E. and Hearing, P. (2005) Functional interaction of the adenovirus IVa2 protein with adenovirus type 5 packaging sequences. J. Virol. 79, 2831-2838
124. Ziedaite, G., Kivela, H. M., Bamford, J. K. and Bamford, D. H. (2009) Purified membrane-containing procapsids of bacteriophage PRD1 package the viral genome. J. Mol. Biol. 386, 637-647
125. Ostapchuk, P. and Hearing, P. (2008) Adenovirus IVa2 protein binds ATP. J. Virol. 82, 10290-10294
126. Ewing, S. G., Byrd, S. A., Christensen, J. B., Tyler, R. E. and Imperiale, M. J. (2007) Ternary complex formation on the adenovirus packaging sequence by the IVa2 and L4 22-kilodalton proteins. J. Virol. 81, 12450-12457
127. Perez-Romero, P., Tyler, R. E., Abend, J. R., Dus, M. and Imperiale, M. J. (2005) Analysis of the interaction of the adenovirus L1 52/55-kilodalton and IVa2 proteins with the packaging sequence in vivoand in vitro. J. Virol. 79, 2366-2374
128. Gupta, S., Mangel, W. F., McGrath, W. J., Perek, J. L., Lee, D. W., Takamoto, K. and Chance, M. R. (2004) DNA binding provides a molecular strap activating the adenovirus proteinase. Mol. Cell. Proteomics 3, 950-959
129. Mangel, W. F., McGrath, W. J., Toledo, D. L. and Anderson, C. W. (1993) Viral DNA and a viral peptide can act as cofactors of adenovirus virion proteinase activity. Nature 361, 274-275
130. Zhang, W. and Imperiale, M. J. (2003) Requirement of the adenovirus IVa2 protein for virus assembly. J. Virol. 77, 3586-3594
131. Tollefson, A. E., Scaria, A., Hermiston, T. W., Ryerse, J. S., Wold, L. J. and Wold, W. S. (1996) The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J. Virol. 70, 2296-2306
132. Chen, P. H., Ornelles, D. A. and Shenk, T. (1993) The adenovirus L3 23-kilodalton proteinase cleaves the amino-terminal head domain from cytokeratin 18 and disrupts the cytokeratin network of HeLa cells. J. Virol. 67, 3507-3514
133. Ying, B. and Wold, W. S. (2003) Adenovirus ADP protein (E3-11.6K), which is required for efficient cell lysis and virus release, interacts with human MAD2B. Virology 313, 224-234
134. Jiang, H., White, E. J., Gomez-Manzano, C. and Fueyo, J. (2008) Adenovirus's last trick: you say lysis, we say autophagy. Autophagy 4, 118-120
135. Muruve, D. A. (2004) The innate immune response to adenovirus vectors. Hum. Gene Ther. 15, 1157-1166
136. Hartman, Z. C., Appledorn, D. M. and Amalfitano, A. (2008) Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications. Virus Res. 132, 1-14
137. Lasaro, M. O. and Ertl, H. C. (2009) New insights on adenovirus as vaccine vectors. Mol. Ther. 17, 1333-1339
138. Chang, C. J., Chen, Y. H., Huang, K. W., Cheng, H. W., Chan, S. F., Tai, K. F. and Hwang, L. H. (2007) Combined GM-CSF and IL-12 gene therapy synergistically suppresses the growth of orthotopic liver tumors. Hepatology 45, 746-754
139. Bremer, E., van Dam, G. M., de Bruyn, M., van Riezen, M., Dijkstra, M., Kamps, G., Helfrich, W. and Haisma, H. (2008) Potent systemic anticancer activity of adenovirally expressed EGFR-selective TRAIL fusion protein. Mol. Ther. 16, 1919-1926
140. Warmann, S. W., Armeanu, S., Heigoldt, H., Ruck, P., Vonthein, R., Heitmann, H., Seitz, G., Lemken, M. L., Bitzer, M., Fuchs, J. and Lauer, U. M. (2009) Adenovirus-mediated cytosine deaminase/5-fluorocytosine suicide gene therapy of human hepatoblastoma in vitro. Pediatr. Blood Cancer 53, 145-151
141. Kirn, D. (2000) Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer. Oncogene 19, 6660-6669
142. Prestwich, R. J., Harrington, K. J., Pandha, H. S., Vile, R. G., Melcher, A. A. and Errington, F. (2008) Oncolytic viruses: a novel form of immunotherapy. Expert Rev. Anticancer Ther. 8, 1581-1588
143. Sinkovics, J. G. and Horvath, J. C. (2008) Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers. Arch. Immunol. Ther. Exp. 56 (Suppl. 1), 3s-59s
144. Dobbelstein, M. (2004) Replicating adenoviruses in cancer therapy. Curr. Top. Microbiol. Immunol. 273, 291-334
145. Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fattaey, A. and McCormick, F. (1996) An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274, 373-376
146. Dorer, D. E. and Nettelbeck, D. M. (2009) Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis. Adv. Drug Delivery Rev. 61, 554-571
147. Rodriguez, R., Schuur, E. R., Lim, H. Y., Henderson, G. A., Simons, J. W. and Henderson, D. R. (1997) Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res. 57, 2559-2563
148. Huang, P. I., Chang, J. F., Kirn, D. H. and Liu, T. C. (2009) Targeted genetic and viral therapy for advanced head and neck cancers. Drug Discovery Today 14, 570-578
149. Aghi, M. and Martuza, R. L. (2005) Oncolytic viral therapies: the clinical experience. Oncogene 24, 7802-7816
150. Chu, R. L., Post, D. E., Khuri, F. R. and Van Meir, E. G. (2004) Use of replicating oncolytic adenoviruses in combination therapy for cancer. Clin. Cancer Res. 10, 5299-5312
151. Li, Y., Pong, R. C., Bergelson, J. M., Hall, M. C., Sagalowsky, A. I., Tseng, C. P., Wang, Z. and Hsieh, J. T. (1999) Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res. 59, 325-330
152. Okegawa, T., Pong, R. C., Li, Y., Bergelson, J. M., Sagalowsky, A. I. and Hsieh, J. T. (2001) The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure. Cancer Res. 61, 6592-6600
153. Wesseling, J. G., Bosma, P. J., Krasnykh, V., Kashentseva, E. A., Blackwell, J. L., Reynolds, P. N., Li, H., Parameshwar, M., Vickers, S. M., Jaffee, E. M. et al. (2001) Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors. Gene Ther. 8, 969-976
154. Matsumoto, K., Shariat, S. F., Ayala, G. E., Rauen, K. A. and Lerner, S. P. (2005) Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer. Urology 66, 441-446
155. Rauen, K. A., Sudilovsky, D., Le, J. L., Chew, K. L., Hann, B., Weinberg, V., Schmitt, L. D. and McCormick, F. (2002) Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. Cancer Res. 62, 3812-3818
156. Huang, K. C., Altinoz, M., Wosik, K., Larochelle, N., Koty, Z., Zhu, L., Holland, P. C. and Nalbantoglu, J. (2005) Impact of the coxsackie and adenovirus receptor (CAR) on glioma cell growth and invasion: requirement for the C-terminal domain. Int. J. Cancer 113, 738-745
157. Anders, M., Vieth, M., Rocken, C., Ebert, M., Pross, M., Gretschel, S., Schlag, P. M., Wiedenmann, B., Kemmner, W. and Hocker, M. (2009) Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression. Br. J. Cancer 100, 352-359
158. Nicklin, S. A., Wu, E., Nemerow, G. R. and Baker, A. H. (2005) The influence of adenovirus fiber structure and function on vector development for gene therapy. Mol. Ther. 12, 384-393
159. Tyler, M. A., Ulasov, I. V., Borovjagin, A., Sonabend, A. M., Khramtsov, A., Han, Y., Dent, P., Fisher, P. B., Curiel, D. T. and Lesniak, M. S. (2006) Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus. Mol. Cancer Ther. 5, 2408-2416
160. Bilbao, G., Contreras, J. L., Dmitriev, I., Smyth, C. A., Jenkins, S., Eckhoff, D., Thomas, F., Thomas, J. and Curiel, D. T. (2002) Genetically modified adenovirus vector containing an RGD peptide in the HI loop of the fiber knob improves gene transfer to nonhuman primate isolated pancreatic islets. Am. J. Transplant. 2, 237-243
161. Zheng, S., Ulasov, I. V., Han, Y., Tyler, M. A., Zhu, Z. B. and Lesniak, M. S. (2007) Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma. J. Gene Med. 9, 151-160
162. Zeng, Y., Pinard, M., Jaime, J., Bourget, L., Uyen Le, P., O'Connor-McCourt, M. D., Gilbert, R. and Massie, B. (2008) A ligand-pseudoreceptor system based on de novo designed peptides for the generation of adenoviral vectors with altered tropism. J. Gene Med. 10, 355-367
163. Paul, C. P., Everts, M., Glasgow, J. N., Dent, P., Fisher, P. B., Ulasov, I. V., Lesniak, M. S., Stoff-Khalili, M. A., Roth, J. C., Preuss, M. A. et al. (2008) Characterization of infectivity of knob-modified adenoviral vectors in glioma. Cancer Biol. Ther. 7, 786-793
164. Le, L. P., Li, J., Ternovoi, V. V., Siegal, G. P. and Curiel, D. T. (2005) Fluorescently tagged canine adenovirus via modification with protein IX-enhanced green fluorescent protein. J. Gen. Virol. 86, 3201-3208
165. Stoff-Khalili, M. A., Rivera, A. A., Glasgow, J. N., Le, L. P., Stoff, A., Everts, M., Tsuruta, Y., Kawakami, Y., Bauerschmitz, G. J., Mathis, J. M. et al. (2005) A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy. Gene Ther. 12, 1696-1706
166. Anderson, B. D., Nakamura, T., Russell, S. J. and Peng, K. W. (2004) High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Cancer Res. 64, 4919-4926
167. Madjd, Z., Durrant, L. G., Pinder, S. E., Ellis, I. O., Ronan, J., Lewis, S., Rushmere, N. K. and Spendlove, I. (2005) Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)? Cancer Immunol. Immunother. 54, 149-156
168. Fishelson, Z., Donin, N., Zell, S., Schultz, S. and Kirschfink, M. (2003) Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors. Mol. Immunol. 40, 109-123
169. Hoffmann, D., Meyer, B. and Wildner, O. (2007) Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses. J. Gene Med. 9, 764-778
170. Tsuruta, Y., Pereboeva, L., Glasgow, J. N., Rein, D. T., Kawakami, Y., Alvarez, R. D., Rocconi, R. P., Siegal, G. P., Dent, P., Fisher, P. B. and Curiel, D. T. (2007) A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway. Clin. Cancer Res. 13, 2777-2783
171. Wang, G., Li, G., Liu, H., Yang, C., Yang, X., Jin, J., Liu, X., Qian, Q. and Qian, W. (2009) E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies. J. Gene Med. 11, 477-485
172. Ganesh, S., Gonzalez-Edick, M., Gibbons, D., Ge, Y., VanRoey, M., Robinson, M. and Jooss, K. (2009) Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer. Cancer Gene Ther. 16, 383-392
173. Toivonen, R., Suominen, E., Grenman, R. and Savontaus, M. (2009) Retargeting improves the efficacy of a telomerase-dependent oncolytic adenovirus for head and neck cancer. Oncol. Rep. 21, 165-171
174. Reddy, P. S., Ganesh, S. and Yu, D. C. (2006) Enhanced gene transfer and oncolysis of head and neck cancer and melanoma cells by fiber chimeric oncolytic adenoviruses. Clin. Cancer Res. 12, 2869-2878
175. Kawakami, Y., Li, H., Lam, J. T., Krasnykh, V., Curiel, D. T. and Blackwell, J. L. (2003) Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication. Cancer Res. 63, 1262-1269
176. Tsuruta, Y., Pereboeva, L., Breidenbach, M., Rein, D. T., Wang, M., Alvarez, R. D., Siegal, G. P., Dent, P., Fisher, P. B. and Curiel, D. T. (2008) A fiber-modified mesothelin promoter-based conditionally replicating adenovirus for treatment of ovarian cancer. Clin. Cancer Res. 14, 3582-3588
177. Kanerva, A., Wang, M., Bauerschmitz, G. J., Lam, J. T., Desmond, R. A., Bhoola, S. M., Barnes, M. N., Alvarez, R. D., Siegal, G. P., Curiel, D. T. and Hemminki, A. (2002) Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses. Mol. Ther. 5, 695-704
178. Kanerva, A., Mikheeva, G. V., Krasnykh, V., Coolidge, C. J., Lam, J. T., Mahasreshti, P. J., Barker, S. D., Straughn, M., Barnes, M. N., Alvarez, R. D. et al. (2002) Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. Clin. Cancer Res. 8, 275-280
179. Rivera, A. A., Davydova, J., Schierer, S., Wang, M., Krasnykh, V., Yamamoto, M., Curiel, D. T. and Nettelbeck, D. M. (2004) Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells. Gene Ther. 11, 1694-1702
180. Guse, K., Ranki, T., Ala-Opas, M., Bono, P., Sarkioja, M., Rajecki, M., Kanerva, A., Hakkarainen, T. and Hemminki, A. (2007) Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses. Mol. Cancer Ther. 6, 2728-2736
181. Kanerva, A., Lavilla-Alonso, S., Raki, M., Kangasniemi, L., Bauerschmitz, G. J., Takayama, K., Ristimaki, A., Desmond, R. A. and Hemminki, A. (2008) Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses. PLoS ONE 3, e2917
182. Murakami, M., Ugai, H., Belousova, N., Pereboev, A., Dent, P., Fisher, P. B., Everts, M. and Curiel, D. T. (2010) Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells. Prostate 70, 362-376
183. Sandberg, L., Papareddy, P., Silver, J., Bergh, A. and Mei, Y. F. (2009) Replication-competent Ad11p vector (RCAd11p) efficiently transduces and replicates in hormone-refractory metastatic prostate cancer cells. Hum. Gene Ther. 20, 361-373
184. Tuve, S., Wang, H., Ware, C., Liu, Y., Gaggar, A., Bernt, K., Shayakhmetov, D., Li, Z., Strauss, R., Stone, D. and Lieber, A. (2006) A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells. J. Virol. 80, 12109-12120
185. Andersson, E. K., Mei, Y. F. and Wadell, G. (2010) Adenovirus interactions with CD46 on transgenic mouse erythrocytes. Virology 402, 20-25
186. Strauss, R., Sova, P., Liu, Y., Li, Z. Y., Tuve, S., Pritchard, D., Brinkkoetter, P., Moller, T., Wildner, O., Pesonen, S. et al. (2009) Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses. Cancer Res. 69, 5115-5125
187. Murakami, S., Sakurai, F., Kawabata, K., Okada, N., Fujita, T., Yamamoto, A., Hayakawa, T. and Mizuguchi, H. (2007) Interaction of penton base Arg-Gly-Asp motifs with integrins is crucial for adenovirus serotype 35 vector transduction in human hematopoietic cells. Gene Ther. 14, 1525-1533
188. Granio, O., Ashbourne Excoffon, K. J., Henning, P., Melin, P., Norez, C., Gonzalez, G., Karp, P. H., Magnusson, M. K., Habib, N., Lindholm, L. et al. (2010) Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia. Hum. Gene Ther. 21, 251-269
189. Abbink, P., Lemckert, A. A., Ewald, B. A., Lynch, D. M., Denholtz, M., Smits, S., Holterman, L., Damen, I., Vogels, R., Thorner, A. R. et al. (2007) Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J. Virol. 81, 4654-4663
190. Vogels, R., Zuijdgeest, D., van Rijnsoever, R., Hartkoorn, E., Damen, I., de Bethune, M. P., Kostense, S., Penders, G., Helmus, N., Koudstaal, W. et al. (2003) Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. J. Virol. 77, 8263-8271
191. Greig, J. A., Buckley, S. M., Waddington, S. N., Parker, A. L., Bhella, D., Pink, R., Rahim, A. A., Morita, T., Nicklin, S. A., McVey, J. H. and Baker, A. H. (2009) Influence of coagulation Factor X on in vitroand in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors. Mol. Ther. 17, 1683-1691
192. Seiradake, E., Henaff, D., Wodrich, H., Billet, O., Perreau, M., Hippert, C., Mennechet, F., Schoehn, G., Lortat-Jacob, H., Dreja, H. et al. (2009) The cell adhesion molecule 'CAR' and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution. PLoS Pathog. 5, e1000277
193. Gimenez-Alejandre, M., Cascallo, M., Bayo-Puxan, N. and Alemany, R. (2008) Coagulation factors determine tumor transduction in vivo. Hum. Gene Ther. 19, 1415-1419
194. Jonsson, M. I., Lenman, A. E., Frangsmyr, L., Nyberg, C., Abdullahi, M. and Arnberg, N. (2009) Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells. J. Virol. 83, 3816-3825
195. Greiff, L., Andersson, M., Erjefalt, J. S., Persson, C. G. and Wollmer, P. (2003) Airway microvascular extravasation and luminal entry of plasma. Clin. Physiol. Funct. Imaging 23, 301-306
196. Perrio, M. J., Ewen, D., Trevethick, M. A., Salmon, G. P. and Shute, J. K. (2007) Fibrin formation by wounded bronchial epithelial cell layers in vitro is essential for normal epithelial repair and independent of plasma proteins. Clin. Exp. Allergy 37, 1688-1700
197. Balakireva, L., Schoehn, G., Thouvenin, E. and Chroboczek, J. (2003) Binding of adenovirus capsid to dipalmitoyl phosphatidylcholine provides a novel pathway for virus entry. J. Virol. 77, 4858-4866
198. Arnberg, N. (2009) Adenovirus receptors: implications for tropism, treatment and targeting. Rev. Med. Virol. 19, 165-178
199. Gonzalez-Chavez, S. A., Arevalo-Gallegos, S. and Rascon-Cruz, Q. (2009) Lactoferrin: structure, function and applications. Int. J. Antimicrob. Agents 33, 301 e301-e308
200. Johansson, C., Jonsson, M., Marttila, M., Persson, D., Fan, X. L., Skog, J., Frangsmyr, L., Wadell, G. and Arnberg, N. (2007) Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells. J. Virol. 81, 954-963
201. Adams, W. C., Bond, E., Havenga, M. J., Holterman, L., Goudsmit, J., Karlsson Hedestam, G. B., Koup, R. A. and Lore, K. (2009) Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN. J. Gen. Virol. 90, 1600-1610
202. Benbrook, D. M. (2006) Organotypic cultures represent tumor microenvironment for drug testing. Drug Discovery Today 3, 143-148
203. Rots, M. G., Elferink, M. G., Gommans, W. M., Oosterhuis, D., Schalk, J. A., Curiel, D. T., Olinga, P., Haisma, H. J. and Groothuis, G. M. (2006) An ex vivohuman model system to evaluate specificity of replicating and non-replicating gene therapy agents. J. Gene Med. 8, 35-41
204. Green, M., Pina, M. and Kimes, R. C. (1967) Biochemical studies on adenovirus multiplication. XII. Plaquing efficiencies of purified human adenoviruses. Virology 31, 562-565
205. Sirena, D., Ruzsics, Z., Schaffner, W., Greber, U. F. and Hemmi, S. (2005) The nucleotide sequence and a first generation gene transfer vector of species B human adenovirus serotype 3. Virology 343, 283-298
206. Mei, Y. F., Skog, J., Lindman, K. and Wadell, G. (2003) Comparative analysis of the genome organization of human adenovirus 11, a member of the human adenovirus species B, and the commonly used human adenovirus 5 vector, a member of species C. J. Gen. Virol. 84, 2061-2071
207. Akusjarvi, G. and Wadell, G. (1989) Genetic map of adenovirus. In Genetic Maps, 5th edn (O'Brien, S., ed.), pp. 1.98-1.101, Cold Spring Harbour Laboratory Press, Cold Spring Harbor